15110-0 |
Morphine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Morphine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
15110-0 |
|
|
|
|
Both |
|
|
|
0 |
Morphine SerPl-sCnc |
|
|
|
Y |
|
Addiction; c260; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Morphine sulfate; MS; MSO4; OMPH; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
15111-8 |
Tricyclic antidepressants |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Tricyclic antidepressants [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
15111-8 |
|
|
|
|
Both |
|
|
|
0 |
Tricyclics SerPl-sCnc |
|
|
|
Y |
|
Antidepres; Antidepressant; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TCA; Tricyclics |
2.34 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
15112-6 |
Phosphatase.leukocyte |
ACnc |
WBC |
Pt |
Qn |
|
|
ACTIVE |
Leukocyte phosphatase [Units/volume] in Leukocytes |
|
MIN |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
HEM/BC |
|
15112-6 |
|
|
|
|
Both |
|
|
|
0 |
LAP WBC-aCnc |
|
|
|
Y |
|
Arbitrary concentration; HEMATOLOGY/CELL COUNTS; LAP; Leuc; Leuk; Leukocyte alkaline phosphatase; Leukocytes; Lkcs; NAT; Neutrophil alkaline phosphatase; Phos; Phosphtase; Point in time; QNT; Quan; Quant; Quantitative; Random; UniversalLabOrders; WBC; WBCs; White blood cell; White blood cells |
2.73 |
1.0k |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
15113-4 |
Aluminum |
SCnc |
Dial fld |
Pt |
Qn |
|
|
ACTIVE |
Aluminum [Moles/volume] in Dialysis fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
15113-4 |
|
|
|
|
Both |
|
|
|
0 |
Aluminum Dial fld-sCnc |
|
|
|
Y |
|
AL; Aluminium; Diaf; Dialysate; Dialysis fluid; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.42 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
15114-2 |
Arsenic |
SCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Arsenic [Moles/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
15114-2 |
|
|
|
|
Both |
|
|
|
0 |
Arsenic Bld-sCnc |
|
|
|
Y |
|
AS; Blood; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
15115-9 |
Arsenic |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Arsenic [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
15115-9 |
|
|
|
|
Both |
|
|
|
0 |
Arsenic Ur-sCnc |
|
|
|
Y |
|
AS; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.34 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
15116-7 |
Arsenic |
SCnc |
Urine |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Arsenic [Molecules/volume] in Urine |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
15116-7 |
|
|
|
|
|
|
|
|
0 |
Deprecated Arsenic Ur-sCnc |
|
|
|
|
|
AS; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.36 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
15117-5 |
Cadmium |
SCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Cadmium [Moles/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
15117-5 |
|
|
|
|
Both |
|
|
|
0 |
Cadmium Bld-sCnc |
|
|
|
Y |
|
Blood; CD; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.34 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
15118-3 |
Chromium |
SCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Chromium [Moles/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
15118-3 |
|
|
|
|
Both |
|
|
|
0 |
Cr Bld-sCnc |
|
|
|
Y |
|
Blood; c609; Chrome; CR; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.75 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
15119-1 |
Cobalt |
SCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Cobalt [Moles/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
15119-1 |
|
|
|
|
Both |
|
|
|
0 |
Cobalt Bld-sCnc |
|
|
|
Y |
|
Blood; c617; CO; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
1512-3 |
Glucose^1M post 0.5 g/kg glucose IV |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --1 minute post 0.5 g/kg glucose IV |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1512-3 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 1M p .5 g/kg Glc IV SerPl-mCnc |
|
|
|
Y |
|
1M p .5 g/kg Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
15120-9 |
Ethanol |
SCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Ethanol [Moles/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
15120-9 |
|
|
|
|
Both |
|
|
|
0 |
Ethanol Bld-sCnc |
|
|
|
Y |
|
Alc; Alcohol; Blood; DRUG/TOXICOLOGY; Drugs; Ethyl alcohol; EtOH; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
15121-7 |
Lipoprotein.alpha/Lipoprotein.total |
MFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lipoprotein.alpha/total Lipoprotein in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15121-7 |
|
|
|
|
Observation |
|
|
|
0 |
HDL MFr SerPl |
|
|
|
Y |
|
Alfa; Chemistry; HDL; High density lipoproteins; Lip; Lipoprot; Lipoproteins; LP; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15122-5 |
Lipoprotein.beta/Lipoprotein.total |
MFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lipoprotein.beta/total Lipoprotein in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15122-5 |
|
|
|
|
Observation |
|
|
|
0 |
LDL MFr SerPl |
|
|
|
Y |
|
B; Chemistry; LDL; Lip; Lipoprot; Lipoproteins; Low density lipoproteins; LP; Mass Fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15123-3 |
Lipoprotein.pre-beta/Lipoprotein.total |
MFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lipoprotein.pre-beta/total Lipoprotein in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15123-3 |
|
|
|
|
Observation |
|
|
|
0 |
VLDL MFr SerPl |
|
|
|
Y |
|
B; Before; Chemistry; Lip; Lipoprot; Lipoproteins; LP; Mass Fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl; Very low density lipoproteins; VLDL |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15124-1 |
Albumin/Protein.total |
MFr |
Synv fld |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Albumin/Protein.total in Synovial fluid by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15124-1 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Albumin MFr Snv Elph |
|
|
|
Y |
|
Alb; Albumin fraction; Albumin%; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Joint aspirate; Joint fld; Joint flu; Joint fluid; Mass fraction; Percent; Point in time; PR; Prot; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; Tot; Totl; TP |
2.7 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15125-8 |
Alpha 1 globulin/Protein.total |
MFr |
Synv fld |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Alpha 1 globulin/Protein.total in Synovial fluid by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15125-8 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Alpha1 Glob MFr Snv Elph |
|
|
|
Y |
|
A1; Alfa; Alpha1 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; i; Joint aspirate; Joint fld; Joint flu; Joint fluid; Mass fraction; Percent; Point in time; PR; Prot; Protein.alpha 1 globulin; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; Tot; Totl; TP |
2.7 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15126-6 |
Alpha 2 globulin/Protein.total |
MFr |
Synv fld |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Alpha 2 globulin/Protein.total in Synovial fluid by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15126-6 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Alpha2 Glob MFr Snv Elph |
|
|
|
Y |
|
A2; Alfa; Alpha2 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Joint aspirate; Joint fld; Joint flu; Joint fluid; Mass fraction; Percent; Point in time; PR; Prot; Protein.alpha 2 globulin; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; Tot; Totl; TP |
2.7 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15127-4 |
Beta globulin/Protein.total |
MFr |
Synv fld |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Beta globulin/Protein.total in Synovial fluid by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15127-4 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
B-Globulin MFr Snv Elph |
|
|
|
Y |
|
B; B-Globulin; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Joint aspirate; Joint fld; Joint flu; Joint fluid; Mass fraction; Percent; Point in time; PR; Prot; Protein beta globulin; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; Tot; Totl; TP |
2.7 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15128-2 |
Gamma globulin/Protein.total |
MFr |
Synv fld |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Gamma globulin/Protein.total in Synovial fluid by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
15128-2 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Gamma glob MFr Snv Elph |
|
|
|
Y |
|
Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Joint aspirate; Joint fld; Joint flu; Joint fluid; Mass fraction; Percent; Point in time; PR; Prot; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; Tot; Totl; TP |
2.7 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
15129-0 |
Fibrin D-dimer |
MCnc |
PPP |
Pt |
Qn |
EIA |
|
DEPRECATED |
Deprecated Fibrin D-dimer EIA |
|
DEL |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
COAG |
|
15129-0 |
|
EIA |
|
|
Order |
|
|
|
0 |
Deprecated D Dimer PPP EIA-mCnc |
|
|
|
Y |
|
COAGULATION; D Dimer; Dextro; ELFA; ELISA; Enzyme immunoassay; Fragment D-dimer; Hematology; Heme; IAA; Level; Mass concentration; MEIA; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; SUDS |
2.36 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
1513-1 |
Glucose^20M post 0.5 g/kg glucose IV |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --20 minutes post 0.5 g/kg glucose IV |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1513-1 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 20M p .5 g/kg Glc IV SerPl-mCnc |
|
|
|
Y |
|
20M p .5 g/kg Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
15130-8 |
Methionine+Tryptophan |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Methionine+Tryptophan [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15130-8 |
|
|
|
|
Both |
|
|
|
0 |
Met+Trp SerPl Ql |
|
|
|
|
|
c244; Chemistry; L-tryptophan; Met; Met+Trp; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Trp |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15131-6 |
Isoleucine+Leucine |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Isoleucine+Leucine [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15131-6 |
|
|
|
|
Both |
|
|
|
0 |
Ile+Leu SerPl Ql |
|
|
|
|
|
Chemistry; Ile; Ile+Leu; Leu; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
15132-4 |
Beta aminoisobutyrate+Proline |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Beta aminoisobutyrate+Proline [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
15132-4 |
|
|
|
|
Observation |
|
|
|
0 |
B-AIB+Pro SerPl Ql |
|
|
|
|
|
3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; B-AIB+Pro; Chemistry; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Pro; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Example" to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |